Clinical Trials
28 trialsPerioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
Emory University
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Seattle Institute for Biomedical and Clinical Research
REVIVE
University Health Network, Toronto
TEMEC
Seattle Institute for Biomedical and Clinical Research
7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy
University of Southern California
ENFORCE
Canisius-Wilhelmina Hospital
Kisspeptin Administration in the Adult
Massachusetts General Hospital
Hormones in Hypogonadotropic Hypogonadism
Medical University of Vienna
Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-Obs
Herlev Hospital
Vitality
Herlev Hospital
Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Centre Hospitalier Universitaire Vaudois
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
University of Kansas Medical Center
Prevalence of Hypogonadism in Male Cancer Patients
Baylor College of Medicine
Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism
Neurocrine UK Limited
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Beth Israel Deaconess Medical Center
HPOS
Weill Medical College of Cornell University
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
National Institutes of Health Clinical Center (CC)
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes
M.D. Anderson Cancer Center
ALCeP
University of Roma La Sapienza
Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors
Rigshospitalet, Denmark
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
Herlev Hospital
Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)
University of Pittsburgh
ADT
National Institutes of Health Clinical Center (CC)
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
GlaxoSmithKline
Older Men and Testosterone
University Hospital of North Norway
Survey of Testosterone Levels in Male Cancer Patients
Beth Israel Medical Center
Prevention of Osteoporosis in Men With Prostate Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Clomiphene in Males With Prolactinomas and Persistent Hypogonadism
Federal University of São Paulo